ストックスクリーナーアプリを入手
1.44
2.86%
0.04
プレマーケット:
1.44
前日終値:
$1.40
開ける：
$1.4
24時間の取引高:
148.20K
Relative Volume:
0.68
時価総額：
$119.02M
収益：
-
当期純損益:
$-21.65M
株価収益率:
-4.336
EPS:
-0.3321
ネットキャッシュフロー:
$-15.84M
1週間 パフォーマンス:
+10.77%
1か月 パフォーマンス:
+12.50%
6か月 パフォーマンス:
+5.88%
1年 パフォーマンス:
-39.24%
1日の値動き範囲:
$1.395
$1.44
1週間の範囲:
$1.14
$1.44
52週間の値動き範囲:
$0.7709
$2.63
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
CRDL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.44 | 115.71M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
153.45 | 67.31B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.74 | 45.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.75 | 43.35B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.58 | 18.68B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
305.61 | 13.44B | 2.99B | 1.21B | 1.13B | 25.06 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-06-26 | 開始されました | ROTH MKM | Buy |
| 2024-04-22 | 開始されました | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc (CRDL) 最新ニュース
Where are the Opportunities in (CRDL) (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics stock holds Buy rating at H.C. Wainwright after trial update - Investing.com Canada
Cardiol Therapeutics Achieves Database Lock in ARCHER Trial for Acute Myocarditis - MSN
What analysts say about Cardiol Therapeutics Inc. stockExplosive wealth accumulation - jammulinksnews.com
What drives Cardiol Therapeutics Inc. stock priceHigh-return market picks - jammulinksnews.com
Cardiol rises on database lockup for acute myocarditis therapy trial - Seeking Alpha
Cardiol To Report ARCHER Study Data Within The Next Two Weeks - Nasdaq
Is Cardiol Therapeutics Inc. a good long term investmentTriple-digit profit margins - jammulinksnews.com
Cardiol Therapeutics Announces Database Lock for Phase II ARCHER - GuruFocus
Cardiol Therapeutics announces database lock for myocarditis trial - Investing.com Australia
Breakthrough Acute Myocarditis Drug Trial Locks Database, Results Due in 2 Weeks - Stock Titan
Cardiol Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - jammulinksnews.com
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - news.stocktradersdaily.com
What's Going On With MongoDB Stock? - The Globe and Mail
(CRDL) Investment Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (NASDAQ:CRDL) Shares Down 8.5% – Here’s What Happened - Defense World
Cardiol Therapeutics shares rise 3.88% premarket after CMS achieves secondary listing on Singapore Exchange. - AInvest
Why Cardiol Therapeutics Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser
How Cardiol Therapeutics Inc. stock performs during market volatilityFree Short-Term Stock Picks - Newser
What makes Cardiol Therapeutics Inc. stock price move sharplyBreakout Momentum Alerts - Newser
(CRDL) On The My Stocks Page (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Stock Market Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (OTCMKTS:CRTPF) Trading Up 10.8% – Still a Buy? - Defense World
Cardiol Therapeutics (TSE:CRDL) Trading Up 1% – Here’s Why - Defense World
(CRDL) Long Term Investment Analysis (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Technical Patterns and Signals (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (TSE:CRDL) Trading Up 2.1% – Here’s What Happened - Defense World
(CRDL) Financial Trading Report (CRDL:CA) - news.stocktradersdaily.com
Analysts Issue Forecasts for CRDL Q2 Earnings - Defense World
All Eyes On ARCHER: Will Cardiol's Drug For Heart Muscle Inflammation Hit The Mark? - RTTNews
Cetera Investment Advisers Takes $56,000 Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World
Cardiol Therapeutics Inc (CRDL) 財務データ
収益
当期純利益
現金流量
EPS
1.34%
大文字化:
|
ボリューム (24 時間):